DGAP-News: Apricus Biosciences Announces Allowance of Israeli Patent, Expanding Its Patent Portfolio for the Topical Treatment of Premature Ejaculation
Apricus Biosciences, Inc.
17.01.2012 16:03
—————————————————————————
SAN DIEGO, 2012-01-17 16:03 CET (GLOBE NEWSWIRE) —
Apricus Biosciences, Inc. (–Apricus Bio– or the –Company–) (Nasdaq:APRI)
(http://www.apricusbio.com) announced today that the Israeli Patent Office
recently issued a Notice of Allowance to grant a patent for the Company–s
development of a topical cream utilizing vasoactive prostaglandin E to treat
premature ejaculation
